ATE446758T1 - Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts - Google Patents
Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstraktsInfo
- Publication number
- ATE446758T1 ATE446758T1 AT01304334T AT01304334T ATE446758T1 AT E446758 T1 ATE446758 T1 AT E446758T1 AT 01304334 T AT01304334 T AT 01304334T AT 01304334 T AT01304334 T AT 01304334T AT E446758 T1 ATE446758 T1 AT E446758T1
- Authority
- AT
- Austria
- Prior art keywords
- growth hormone
- secretagogenes
- prodrug
- motility
- promote digestive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20823400P | 2000-05-31 | 2000-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE446758T1 true ATE446758T1 (de) | 2009-11-15 |
Family
ID=22773794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01304334T ATE446758T1 (de) | 2000-05-31 | 2001-05-16 | Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts |
Country Status (14)
Country | Link |
---|---|
US (2) | US6548501B2 (de) |
EP (1) | EP1159964B1 (de) |
JP (4) | JP3842987B2 (de) |
KR (1) | KR20010109139A (de) |
AT (1) | ATE446758T1 (de) |
AU (1) | AU4811401A (de) |
CA (1) | CA2349142C (de) |
DE (1) | DE60140285D1 (de) |
ES (1) | ES2333097T3 (de) |
HU (1) | HUP0102272A3 (de) |
IL (1) | IL143388A0 (de) |
MY (1) | MY134190A (de) |
NZ (1) | NZ512072A (de) |
ZA (1) | ZA200104396B (de) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6494888B1 (en) * | 1999-06-22 | 2002-12-17 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6663639B1 (en) | 1999-06-22 | 2003-12-16 | Ndo Surgical, Inc. | Methods and devices for tissue reconfiguration |
US8287554B2 (en) * | 1999-06-22 | 2012-10-16 | Ethicon Endo-Surgery, Inc. | Method and devices for tissue reconfiguration |
US6835200B2 (en) * | 1999-06-22 | 2004-12-28 | Ndo Surgical. Inc. | Method and devices for tissue reconfiguration |
US6821285B2 (en) * | 1999-06-22 | 2004-11-23 | Ndo Surgical, Inc. | Tissue reconfiguration |
US7846180B2 (en) | 1999-06-22 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Tissue fixation devices and methods of fixing tissue |
EP1149583A3 (de) * | 2000-04-13 | 2001-11-14 | Pfizer Products Inc. | Kombinationen bestehend aus Antagonisten des Corticotropin freisetzenden Faktors und Stoffen, die die Wachstumshormonsekretion fördern |
DE60140285D1 (de) * | 2000-05-31 | 2009-12-10 | Pfizer Prod Inc | Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts |
EP1312363A1 (de) * | 2001-09-28 | 2003-05-21 | Pfizer Products Inc. | Behandlungsverfahren und kits bestehend aus Wachstumshormonsekretionsförderern |
US7476653B2 (en) * | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
US20090198050A1 (en) * | 2003-06-18 | 2009-08-06 | Tranzyme Pharma Inc. | Macrocyclic Modulators of the Ghrelin Receptor |
DK1633774T3 (da) | 2003-06-18 | 2010-05-25 | Tranzyme Pharma Inc | Makrocykliske motilinreceptorantagonister |
US8921521B2 (en) | 2003-06-18 | 2014-12-30 | Ocera Therapeutics, Inc. | Macrocyclic modulators of the Ghrelin receptor |
US7491695B2 (en) | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
USRE42624E1 (en) | 2003-06-18 | 2011-08-16 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
USRE42013E1 (en) | 2003-06-18 | 2010-12-28 | Tranzyme Pharma Inc. | Macrocyclic modulators of the ghrelin receptor |
CN1812815A (zh) * | 2003-06-25 | 2006-08-02 | 霍夫曼-拉罗奇有限公司 | 氚化的生长激素促分泌素 mk-0677 |
CA2533818C (en) * | 2003-07-31 | 2015-03-17 | Tranzyme Pharma, Inc. | Spatially-defined macrocyclic compounds useful for drug discovery |
WO2005021026A2 (en) * | 2003-08-29 | 2005-03-10 | Amylin Pharmaceuticals, Inc. | Methods for treating or ameliorating ghrelin-associated diseases and disorders |
IL158658A0 (en) * | 2003-10-29 | 2004-05-12 | Moshe Schwarzberg | Prokinetic drugs assistance to small intestine imaging |
US20050261201A1 (en) * | 2004-03-30 | 2005-11-24 | Rejuvenon Corporation | Method of reducing C-reactive protein using growth hormone secretagogues |
US8129359B2 (en) | 2004-06-04 | 2012-03-06 | Ethicon, Inc. | Composition and method for treating post-surgical pain |
US8377906B2 (en) * | 2004-06-04 | 2013-02-19 | Ethicon, Inc. | Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
US20070141156A1 (en) * | 2005-12-21 | 2007-06-21 | Uri Herzberg | Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
PE20060574A1 (es) | 2004-07-28 | 2006-06-24 | Glaxo Group Ltd | Derivados de arilpiperazina sulfonamida como agonistas de los receptores de secretagogos de la hormona del crecimiento (ghs) |
US8039456B2 (en) | 2004-08-12 | 2011-10-18 | Helsinn Therapeutics (U.S.), Inc. | Method of stimulating the motility of the gastrointestinal system using ipamorelin |
KR101380200B1 (ko) * | 2004-08-12 | 2014-04-01 | 헬신 세라퓨틱스 (유.에스.) 인크. | 성장 호르몬 분비촉진제를 이용하여 위장관계의 운동성을촉진하는 방법 |
JP2008510706A (ja) * | 2004-08-18 | 2008-04-10 | エリクシアー ファーマシューティカルズ, インコーポレイテッド | 成長ホルモン分泌促進物質 |
US20090275648A1 (en) * | 2005-06-13 | 2009-11-05 | Fraser Graeme L | Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
JP4879265B2 (ja) * | 2005-07-22 | 2012-02-22 | イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ | 成長ホルモン分泌促進薬 |
SI1937262T1 (sl) | 2005-09-29 | 2019-09-30 | Ipsen Pharma | Spojina za uporabo pri zdravljenju gastrointestinalne dismotilitete |
US7576606B2 (en) * | 2007-07-25 | 2009-08-18 | D2Audio Corporation | Digital PWM amplifier having a low delay corrector |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
PE20080145A1 (es) | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
AR060213A1 (es) | 2006-03-31 | 2008-06-04 | Glaxo Group Ltd | Compuesto de piperazinil - piridinil -bencensulfonamida , su uso para fabricar un medicamento proceso para la preparacion del mismo composicion farmaceutica que lo comprende y proceso para prepararla |
US8088733B2 (en) | 2006-07-06 | 2012-01-03 | Tranzyme Pharma Inc. | Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders |
JP5649825B2 (ja) | 2007-01-31 | 2015-01-07 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | 安定化させたp53ペプチドおよびその使用法 |
BRPI0807046A2 (pt) | 2007-02-09 | 2015-05-26 | Tranzyme Pharma Inc | Composto, composição farmacêutica, métodos de tratar um distúrbio, uma doença cardiovascular e um paciente que sofre de motilidade gastrointestinal reduzida ou disfuncional e, kit. |
AU2008216789A1 (en) * | 2007-02-13 | 2008-08-21 | Helsinn Therapeutics (U.S.), Inc. | Method of treating cell proliferative disorders using growth hormone secretagogues |
US20080234703A1 (en) * | 2007-03-23 | 2008-09-25 | Ethicon Endo-Surgery, Inc. | Tissue approximation system |
US8852216B2 (en) | 2007-03-23 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Tissue approximation methods |
JP5631201B2 (ja) | 2007-03-28 | 2014-11-26 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ステッチングされたポリペプチド |
TWI429436B (zh) * | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | 使用生長激素促泌素治療或預防嘔吐之方法 |
US7728658B2 (en) * | 2007-07-25 | 2010-06-01 | D2Audio Corporation | Low-noise, low-distortion digital PWM amplifier |
WO2009078999A1 (en) | 2007-12-17 | 2009-06-25 | Janssen Pharmaceutica N.V. | Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
AU2008341160A1 (en) * | 2007-12-21 | 2009-07-02 | Helsinn Therapeutics (U.S.), Inc. | Method of stimulating the motility of the gastrointestinal system using ipamorelin |
WO2010023480A1 (en) * | 2008-08-29 | 2010-03-04 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Saturated bicyclic heterocyclic derivatives as smo antagonists |
KR100991032B1 (ko) * | 2008-12-08 | 2010-10-29 | 삼일제약주식회사 | 위장관 운동 조절용 약학 조성물 |
KR20120131183A (ko) * | 2010-02-26 | 2012-12-04 | 라퀄리아 파마 인코포레이티드 | 악액질 치료용 그렐린 수용체 작용제 |
RU2016111360A (ru) | 2010-08-13 | 2018-11-27 | Эйлерон Терапьютикс, Инк. | Пептидомиметические макроциклы |
AR086554A1 (es) * | 2011-05-27 | 2014-01-08 | Novartis Ag | Derivados de la piperidina 3-espirociclica como agonistas de receptores de la ghrelina |
KR20140100937A (ko) | 2011-10-18 | 2014-08-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
JP6450192B2 (ja) | 2012-02-15 | 2019-01-09 | エイルロン セラピューティクス,インコーポレイテッド | トリアゾール架橋した、およびチオエーテル架橋したペプチドミメティック大環状化合物 |
CN107216380A (zh) | 2012-02-15 | 2017-09-29 | 爱勒让治疗公司 | 拟肽大环化合物 |
PT3524260T (pt) | 2012-09-27 | 2023-10-13 | Elanco Animal Health Incorporated | Composições farmacêuticas para o tratamento de inapetência |
JP6526563B2 (ja) | 2012-11-01 | 2019-06-05 | エイルロン セラピューティクス,インコーポレイテッド | 二置換アミノ酸ならびにその調製および使用の方法 |
CA2961258A1 (en) | 2014-09-24 | 2016-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
WO2016154058A1 (en) | 2015-03-20 | 2016-09-29 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
JP6299683B2 (ja) | 2015-06-25 | 2018-03-28 | トヨタ自動車株式会社 | 燃料電池システム |
UA123865C2 (uk) | 2015-09-21 | 2021-06-16 | Люмос Фарма, Інк | Визначення та лікування дефіциту гормону росту |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4411890A (en) | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4962115A (en) | 1981-10-01 | 1990-10-09 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
AU637316B2 (en) | 1988-01-28 | 1993-05-27 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
EP0398961B1 (de) | 1988-01-28 | 1994-11-02 | Polygen Holding Corporation | Polypeptidverbindungen mit wachstumshormonfreisetzender aktivität |
US5663146A (en) | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
US5726319A (en) | 1992-11-06 | 1998-03-10 | Merck & Co., Inc. | Biphenyl substituted dipeptide analogs promote release of growth hormone |
WO1994011012A1 (en) | 1992-11-06 | 1994-05-26 | Merck & Co., Inc. | Substituted dipeptide analogs promote release of growth hormone |
HUT72076A (en) | 1992-12-11 | 1996-03-28 | Merck & Co Inc | Process for preparing spiro piperidines and homologs which promote release of growth hormone and pharmaceutical compositions containing them |
US5578593A (en) | 1992-12-11 | 1996-11-26 | Merck & Co., Inc. | Spiro piperidines and homologs promote release of growth hormone |
CA2173333A1 (en) | 1993-10-19 | 1995-04-27 | Barry J. Gertz | Combination of bisphosphonates and growth hormone secretagogues |
US5492916A (en) | 1993-12-23 | 1996-02-20 | Merck & Co., Inc. | Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
US5494919A (en) | 1993-11-09 | 1996-02-27 | Merck & Co., Inc. | 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
EP0739204A4 (de) | 1993-11-09 | 2000-03-15 | Merck & Co Inc | Piperidine, pyrrolidine und hexahydro-1h-azepine unterstützen die freisetzung des wachstumshormon |
WO1995014666A1 (en) | 1993-11-24 | 1995-06-01 | Merck & Co., Inc. | Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s) |
US5721251A (en) | 1993-12-10 | 1998-02-24 | Merck & Co., Inc. | Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone |
WO1995017423A1 (en) | 1993-12-23 | 1995-06-29 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
CZ291382B6 (cs) | 1993-12-23 | 2003-02-12 | Novo Nordisk A/S | Peptidické deriváty ovlivňující uvolňování růstového hormonu, farmaceutický přípravek je obsahující a jejich použití |
US5721250A (en) | 1993-12-23 | 1998-02-24 | Merck & Co. Inc. | Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
US5777112A (en) | 1994-06-13 | 1998-07-07 | Merck & Co., Inc | Piperazine compounds promote release of growth hormone |
AU3128195A (en) | 1994-07-20 | 1996-02-16 | Merck & Co., Inc. | Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone |
US5798337A (en) | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
WO1996022996A1 (fr) | 1995-01-25 | 1996-08-01 | Nippon Chemiphar Co., Ltd. | Derives de dihydrophenazine |
AU705744B2 (en) | 1995-01-27 | 1999-06-03 | Sapphire Therapeutics, Inc. | Compounds with growth hormone releasing properties |
AU4534696A (en) | 1995-02-09 | 1996-08-27 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
AU4534596A (en) | 1995-02-09 | 1996-08-27 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US5559128A (en) | 1995-04-18 | 1996-09-24 | Merck & Co., Inc. | 3-substituted piperidines promote release of growth hormone |
EP0823904A4 (de) | 1995-04-19 | 1998-09-09 | Merck & Co Inc | Verfahren zur herstellung von spiroindolinen |
WO1996038471A1 (en) | 1995-05-29 | 1996-12-05 | Pfizer Inc. | Dipeptides which promote release of growth hormone |
WO1996035713A1 (en) | 1995-05-08 | 1996-11-14 | Pfizer, Inc. | Dipeptides which promote release of growth hormone |
EP0833845A1 (de) | 1995-06-22 | 1998-04-08 | Novo Nordisk A/S | Verbindungen mit wachstumshormon-freisetzenden eigenschaften |
CA2203428A1 (en) | 1995-08-21 | 1997-02-27 | Philip Arthur Hipskind | 2-acylaminopropanamides as growth hormone secretagogues |
CA2203424A1 (en) | 1995-08-21 | 1997-02-27 | Eli Lilly And Company | 2-acylaminopropanamines as growth hormone secretagogues |
AU7169696A (en) | 1995-09-26 | 1997-04-17 | Merck & Co., Inc. | 3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone |
WO1997015573A1 (en) | 1995-10-27 | 1997-05-01 | Merck & Co., Inc. | Process for the preparation of a growth hormone secretagogue |
ES2268713T3 (es) | 1995-12-13 | 2007-03-16 | MERCK & CO., INC. | Ensayos de receptores de secretagogos de la hormona de crecimiento. |
JP3754084B2 (ja) | 1995-12-13 | 2006-03-08 | メルク エンド カンパニー インコーポレーテッド | 成長ホルモン分泌促進薬受容体ファミリー |
WO1997022367A1 (en) | 1995-12-20 | 1997-06-26 | Merck & Co., Inc. | Radiolabeled growth hormone secretagogue |
IT1277113B1 (it) | 1995-12-20 | 1997-11-04 | Romano Deghenghi | Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita |
AU715856B2 (en) | 1995-12-22 | 2000-02-10 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
WO1997034604A1 (en) | 1996-03-21 | 1997-09-25 | Merck & Co., Inc. | 4-spiroindoline piperidines promote release of growth hormone |
AU2722297A (en) | 1996-04-03 | 1997-10-22 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
SE9601397D0 (sv) | 1996-04-12 | 1996-04-12 | Pharmacia Ab | Use of growth hormone |
JP2000510453A (ja) | 1996-04-19 | 2000-08-15 | ノボ ノルディスク アクティーゼルスカブ | 成長ホルモン遊離特性を有する化合物 |
HUP9902668A3 (en) | 1996-04-24 | 2000-07-28 | Novo Nordisk As | Piperazine derivatives, pharmaceutical compositions containing them and their use |
US5919777A (en) | 1996-04-24 | 1999-07-06 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
AU2931997A (en) | 1996-05-07 | 1997-11-26 | Merck & Co., Inc. | Treatment of mood disorders with a growth hormone secretagogue |
WO1997043278A1 (en) | 1996-05-14 | 1997-11-20 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
WO1997044042A1 (en) | 1996-05-22 | 1997-11-27 | Arch Development Corporation | Sleep quality improvement using a growth hormone secretagogue |
EP0907374A1 (de) | 1996-05-31 | 1999-04-14 | Novo Nordisk A/S | Wachstumshormonkomponente sowie wirkstoff, der von knochen nicht resorbiert wird, zur zyklischen (kohärenten) behandlung von osteoporese |
DE69713109T2 (de) | 1996-07-22 | 2003-01-02 | Novo Nordisk A/S, Bagsvaerd | Verbindungen mit wachstumshormon freisetzenden eigenschaften |
AU4342097A (en) | 1996-09-13 | 1998-04-02 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
AU6747498A (en) | 1997-04-11 | 1998-11-11 | Sumitomo Pharmaceuticals Company, Limited | Benzene derivatives |
JP2000514838A (ja) | 1997-05-14 | 2000-11-07 | 藤沢薬品工業株式会社 | 成長ホルモンの放出を促進するピペリジノ誘導体 |
AU7906998A (en) | 1997-06-20 | 1999-01-04 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
UA53716C2 (uk) * | 1997-06-25 | 2003-02-17 | Пфайзер Продактс Інк. | Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти) |
AU7445498A (en) * | 1997-06-25 | 1999-01-04 | Pfizer Inc. | Dipeptide derivatives as growth hormone secretagogues |
UA64751C2 (uk) | 1997-06-25 | 2004-03-15 | Пфайзер Продактс Інк. | Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти) |
ZA987383B (en) | 1997-08-19 | 2000-02-17 | Lilly Co Eli | Treatment of congestive heart failure with growth hormone secretagogues. |
WO1999009991A1 (en) | 1997-08-22 | 1999-03-04 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives |
US6211174B1 (en) * | 1997-10-31 | 2001-04-03 | Merck & Co., Inc. | Naphtho-fused lactams promote release of growth hormone |
US6358951B1 (en) * | 1998-08-21 | 2002-03-19 | Pfizer Inc. | Growth hormone secretagogues |
US6194578B1 (en) * | 1998-11-20 | 2001-02-27 | Pfizer Inc. | Dipeptide derivatives |
EP1190059A1 (de) * | 1999-06-30 | 2002-03-27 | ZymoGenetics, Inc. | Sgip peptide |
WO2001091752A1 (en) * | 2000-05-30 | 2001-12-06 | Merck & Co., Inc. | Melanocortin receptor agonists |
DE60140285D1 (de) * | 2000-05-31 | 2009-12-10 | Pfizer Prod Inc | Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts |
-
2001
- 2001-05-16 DE DE60140285T patent/DE60140285D1/de not_active Expired - Lifetime
- 2001-05-16 ES ES01304334T patent/ES2333097T3/es not_active Expired - Lifetime
- 2001-05-16 EP EP01304334A patent/EP1159964B1/de not_active Expired - Lifetime
- 2001-05-16 AT AT01304334T patent/ATE446758T1/de not_active IP Right Cessation
- 2001-05-24 IL IL14338801A patent/IL143388A0/xx unknown
- 2001-05-29 KR KR1020010029620A patent/KR20010109139A/ko active Search and Examination
- 2001-05-29 ZA ZA200104396A patent/ZA200104396B/xx unknown
- 2001-05-29 MY MYPI20012552 patent/MY134190A/en unknown
- 2001-05-29 CA CA002349142A patent/CA2349142C/en not_active Expired - Lifetime
- 2001-05-30 AU AU48114/01A patent/AU4811401A/en not_active Abandoned
- 2001-05-30 HU HU0102272A patent/HUP0102272A3/hu unknown
- 2001-05-30 NZ NZ512072A patent/NZ512072A/xx unknown
- 2001-05-30 US US09/870,105 patent/US6548501B2/en not_active Expired - Lifetime
- 2001-05-31 JP JP2001164877A patent/JP3842987B2/ja not_active Expired - Lifetime
-
2003
- 2003-04-11 US US10/411,756 patent/US6852722B2/en not_active Expired - Lifetime
-
2006
- 2006-07-03 JP JP2006183577A patent/JP2006265270A/ja not_active Withdrawn
-
2013
- 2013-04-19 JP JP2013088135A patent/JP2013139482A/ja not_active Withdrawn
-
2015
- 2015-04-06 JP JP2015077334A patent/JP2015127344A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1159964B1 (de) | 2009-10-28 |
NZ512072A (en) | 2002-10-25 |
ZA200104396B (en) | 2002-11-29 |
IL143388A0 (en) | 2002-04-21 |
CA2349142A1 (en) | 2001-11-30 |
JP3842987B2 (ja) | 2006-11-08 |
JP2002012556A (ja) | 2002-01-15 |
CA2349142C (en) | 2005-07-12 |
JP2015127344A (ja) | 2015-07-09 |
JP2006265270A (ja) | 2006-10-05 |
HU0102272D0 (en) | 2001-08-28 |
JP2013139482A (ja) | 2013-07-18 |
EP1159964A2 (de) | 2001-12-05 |
KR20010109139A (ko) | 2001-12-08 |
EP1159964A3 (de) | 2003-10-01 |
AU4811401A (en) | 2001-12-06 |
US20030225096A1 (en) | 2003-12-04 |
HUP0102272A3 (en) | 2003-09-29 |
ES2333097T3 (es) | 2010-02-17 |
US6548501B2 (en) | 2003-04-15 |
DE60140285D1 (de) | 2009-12-10 |
US6852722B2 (en) | 2005-02-08 |
HUP0102272A2 (hu) | 2002-02-28 |
MY134190A (en) | 2007-11-30 |
US20020042419A1 (en) | 2002-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE446758T1 (de) | Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts | |
MXPA04005906A (es) | Cis-2,4,5-trifenil-.imidazolinas y uso de la misma para tratamiento de tumores. | |
ATE272398T1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
HK1069339A1 (en) | Substituted diketopiperazines as oxytocin antagonists | |
TNSN04165A1 (en) | Substituted hydroxyethylamines | |
ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
MY152921A (en) | Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives | |
IL169257A0 (en) | Cycloalkene dicarboxylic acid compounds as anti-infammatory, immunomodulatory and anti-proliferatory agents | |
EP1175900A3 (de) | Verwendung von Sekretionsfördermittel für Wachstumshormone zu Verbesserung des funktionellen Gesundheitsstatus | |
EP1184035A3 (de) | Verwendung von Sekretionsfördermitteln für Wachstumshormone zu Behandlung des physischen Leistungsabbaus | |
ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
MXPA03011626A (es) | Derivados de quinazolina que promueven la liberacion de hormona paratiroides. | |
HK1075894A1 (en) | Prucalopride-n-oxide | |
EP1181933A3 (de) | Verwendung von wachstumshormonsekretion-fördernden mitteln zur appetit erholung | |
WO2002058680A3 (en) | Use of bicylic amino acids for preventing and treating visceral pain and gastrointestinal disorders | |
DE602004030265D1 (de) | Behandlung von gastrointestinalen stromatumoren mit imatinib und midostaurin | |
DE60022047D1 (de) | Antivirale therapie | |
DE60104288D1 (de) | Antivirale therapie | |
ATE288254T1 (de) | Methode zur behandlung von schlaganfall | |
RU2000122595A (ru) | Лекарственное средство для лечения пиелонефрита | |
WO2003004019A8 (en) | Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin a for the treatment of beta-thalassaemia | |
TH51180A (th) | วิธีสำหรับการรักษาโรคพาร์คินสันโดยการให้ (-)-5- คีโท-2-N,N-ได-n-โปรพิลอะมิโน-เตตระไฮโดรเตตระลิน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |